Lv3
300 积分 2024-02-21 加入
Predicting Formulation Conditions During Ultrafiltration and Dilution to Drug Substance Using a Donnan Model with Homology-Model Based Protein Charge
16天前
已完结
Subcutaneous Administration of Therapeutic Monoclonal Antibody Drug Products Using a Syringe in Blinded Clinical Trials: Advances and Key Aspects Related to Blinding/Matching/Masking Strategies for Placebo Formulation
16天前
已完结
Monitoring of low-molecular-weight protein aggregation by CE-SDS as a complementary method to SE-HPLC
17天前
已完结
LUMI-lab: A foundation model-driven autonomous platform enabling discovery of ionizable lipid designs for mRNA delivery
22天前
已完结
What influences the activity of Degrader−Antibody conjugates (DACs)
1个月前
已完结
Molecular glue meets antibody: next-generation antibody–drug conjugates
1个月前
已完结
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
1个月前
已完结
Characterization of antibody drug conjugate positional isomers at cysteine residues by peptide mapping LC–MS analysis
1个月前
已完结
Histidine as a versatile excipient in the protein-based biopharmaceutical formulations
2个月前
已完结
Impact of Extractables/Leachables from Filter Materials on the Stability of Protein-Based Pharmaceutical Products
2个月前
已完结
皖公网安备34019202002308
